Inhibition of nitric oxide production and the effects of arginine and Lactobacillus administration in an acute liver injury model

Annals of Surgery

Volumn 228, Issue 6, 1998, Pages 748-755

  Adawi, Diya ^a   Molin, Göran ^a   Jeppsson, Bengt ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BILIRUBIN; DNA; GALACTOSAMINE; LIVER ENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NUCLEOTIDE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL TRANSLOCATION; CELL METABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MIXTURE; ENTEROBACTERIACEAE; HEPATITIS; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LIVER INJURY; LIVER SURGERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; BACTERIAL TRANSLOCATION; CECUM; COLON; DNA; INTESTINAL MUCOSA; LACTOBACILLUS; LIVER; LIVER FUNCTION TESTS; MALE; NITRIC OXIDE; NUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; RNA;

EID: 0032471950     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199812000-00005     Document Type: Conference Paper

References (46)

1. Barbul A. Arginine: biochemistry, physiology and therapeutic implication. J Parenteral Enteral Nutri 1986; 10:227-238.
2. Daly JM, Reynolds J, Thorn A, et al. Immune and metabolic effects of arginine in surgical patients. Ann Surg 1988; 208:512-523.
3. Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 1981; 90:244-251.
4. Iyengar R, Stueher DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate and N-nitrosoamines: precursors and the role of the respiratory burst. Proc Natl Acad Sci USA 1987; 84:6369-6373.
5. Kelly E, Morris Jr SM, Billiar TR. Nitric oxide, sepsis, and arginine metabolism. J Parenteral Enteral Nutrition 1995; 19:234-238.
6. Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacillic fermented diary products. FEMS Microbiol Rev 1987; 46:343-356.
7. Axelsson L. Lactobacillus reuteri, a member of the gut bacterial flora (thesis). Uppsala, Sweden: Swedish University of Agricultural Sciences, Dept. of Microbiology, 1990.
8. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31:1231-1233.
9. Axelsson LT, Chung TC, Dobrogsz WJ, Lindgren SE. Production of broad-spectrum antimicrobial substance by Lactobacillus reuteri. Micr Ecol Health Dis 1989; 2:131-136.
10. Gilliland SE, Speck ML. Antagonistic action of Lactobacillus acidophilus toward intestinal and food-born pathogens in associative cultures. J Food Prot 1977; 40:820-823.
11. Fuller R. Probiotics in human medicine. Gut 1991; 32:439-442.
12. Sato K, Saito H, Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol Immunol 1988; 32(7):689-698.
13. Perdigon G, Alvarez S, De Macias ME, Roux ME, De Ruizholgado AP. The oral administration of lactic acid bacteria increases the mucosal intestinal immunity in response to enteropathogens. J Food Prot 1990; 53(5):404-410.
14. Mao Y, Nobaek S, Kasravi B, et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996; 111:334-344.
15. Abdelal TA. Arginine catabolism by microorganisms. Annu Rev Microbiol 1979; 33:139-168.
16. Manca De Narda MC, Pesce De Ruiz H. Arginine dihydrolase activity in lactic acid bacteria. Milchenwissenschaft 1982; 37:669-670.
17. Bismuth H, Samuel D, Gugenheim J. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107:337-341.
18. Rakela J, Lange SM, Ludwig J. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985; 60:289-292.
19. Van-Leeuwen PA, Boemeester MA, Houdijk AP, et al. Clinical significance of translocation. Gut 1994; 35(supp):328-334.
20. Adawi D, Kasravi FB, Molin G, Jeppsson B. Effect of Lactobacillus administration with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology 1997; 25:642-647.
21. Johansson ML, Molin G, Jeppsson B, et al. Administration of different Lactobacillus strains in fermented oatmeal soup. Appl Environ Microbiol 1993; 59:15-20.
22. Sommer BG, Sutherland DER, Matas AJ, Simmons RL, Najarian JS. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats. Transplant Proc 1979; 11:1032-1038.
23. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended method for the determination of four enzymes in the blood. Scand J Clin Lab Invest 1974; 33:291-306.
24. Munro HN, Fleek A. Recent developments in the measurement of nucleic acid in biological materials. Analyst 1966; 91:78-88.
25. Scott JE, Franccastro AP, Taft EB. Studies in biochemistry: I. Determination of nucleic acid in microgram amounts of tissue. Histochem Cytochem 1956; 4:1-10.
26. Godfrey K. Comparing the means of several groups. In Bailar III JC, Mosteller F, eds. Medical uses of statistics. Waltham, Mass.: New England Journal of Medicine Books, 1986:205-234.
27. Kuo PC, Slivka A. Nitric oxide decreases oxidant-mediated hepatocyte injury. J Surg Res 1994; 56:594-600.
28. Billiar TR, Curran RD, Steuhr DJ, Hoffmann K, Simmons RL. Inhibition of L-arginine metabolism by NG-monomethyl-L-arginine in vivo promotes hepatic damage in response to lipopolysaccharide. In Moncada S, Higgs EA, eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Elsevier, 1990:275-280.
29. Manca De Narda MC, Aida A, Pesce de Ruizholgado, Oliver G. Arginine dihydrolase pathway in Lactobacillus buchneri: a review. Biochemie 1988; 70:367-374.
30. Hibbs JB, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235:473-476.
31. Marletta MA, Yoon PS, Iyengar R, et al. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27:8706-8711.
32. Jonsson S, Clausen E, Raa J. Amino acid degradation by a Lactobacillus plantarum strain from fish. System Appl Microbiol 1983; 4: 148-154.
33. Vos TA, Gouw AS, Klok PA, et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113:1323-1333.
34. Nathan CF, Hibbs Jr JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3:65-70.
35. James LS. Role of nitric oxide in parasitic infections. Microbiol Rev 1995; 59(4):533-547.
36. Carson JJ, Torres AV, Van Der Heyde HC, et al. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Medicine 1995; 1(6):552-557.
37. Billiar TR, Langrehr JM, Curran RD, et al. Two unique aspects of inducible nitric oxide synthase in liver cells and accessory cells: hepatic damage is minimized by hepatocyte nitric oxide production and immunoregulation is mediated by macrophage nitric oxide. Res Immunol 1992; 142:584-586.
38. Boughton-Smith NK, Hutcheson IR, Deakin AM, Whittle BJR, Moncada S. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990; 191:485-488.
39. Green SJ. Nitric oxide in mucosal immunity. Nature Medicine 1995; 1(6):515-517.
40. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992; 262 (Gastrointest Liver Physiol 25):G1138-G1142.
41. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266 (Gastrointest Liver Physiol 29):G222-G229.
42. Whittle BRJ, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interaction with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99:607-611.
43. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101:815-820.
44. Mao Y, Yu J-L, Ljungh Å, Molin G, Jeppsson B. Intestinal immune response to oral administration of Lactobacillus reuteri R2LC, Lactobacillus DSM 9843, pectin and oatbase on methotrexate-induced enterocolitis in rats. Microbial Ecol Health Dis 1996; 9:261-270.
45. Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997; 113(4):1246-1257.
46. Goodlad RA, Wright NA. Changes in intestinal cell proliferation, absorptive capacity and structure in young, adult and old rats. J Anat 1990; 173:109-118.